SCHEMBL30358255

SCHEMBL30358255

O=C(Cc1cccc(C(F)(F)F)c1)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 19/20 1.00
RIPK3 Q9Y572 17/20 1.00
CHEK1 O14757 1/20 0.74
IKBKB O14920 1/20 0.74
RAF1 P04049 1/20 0.74
PDGFA P04085 1/20 0.74
CDK1 P06493 1/20 0.74
PDGFRB P09619 1/20 0.74
CCNB1 P14635 1/20 0.74
BRAF P15056 1/20 0.74
CCNA2 P20248 1/20 0.74
FGFR3 P22607 1/20 0.74
CDK2 P24941 1/20 0.74
KDR P35968 1/20 0.74
GSK3B P49841 1/20 0.74
MAP2K1 Q02750 1/20 0.74
TEK Q02763 1/20 0.74
MAPK14 Q16539 1/20 0.74
AURKB Q96GD4 1/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25412537 1.00 RIPK1 (1.00) RIPK1RIPK3CHEK1IKBKBRAF1
SCHEMBL29025422 0.96 RIPK1 (0.93) RIPK1RIPK3CHEK1IKBKBRAF1
SCHEMBL29525811 0.93 RIPK3 (0.87) RIPK1RIPK3CHEK1IKBKBRAF1
SCHEMBL29025431 0.89 RIPK1 (0.94) RIPK1RIPK3CHEK1IKBKBRAF1
SCHEMBL2453182 0.89 RIPK1 (0.80) RIPK1RIPK3CHEK1IKBKBRAF1
SCHEMBL22275546 0.88 RIPK1 (0.82) RIPK1RIPK3CHEK1IKBKBRAF1
SCHEMBL823638 0.87 RIPK1 (0.81) RIPK1RIPK3CHEK1IKBKBRAF1
SCHEMBL28496454 0.87 RIPK1 (0.81) RIPK1RIPK3CHEK1IKBKBRAF1
SCHEMBL29525629 0.87 RIPK1 (1.00) RIPK1RIPK3CHEK1IKBKBRAF1
SCHEMBL29025446 0.86 RIPK1 (0.88) RIPK1RIPK3CHEK1IKBKBRAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230277538-A1 THERAPEUTICS FOR THE TREATMENT OF FSHD UCL BUSINESS LTD (GB) 2023-09-07 US claimed
EP-4171534-A1 THERAPEUTICS FOR THE TREATMENT OF FSHD UCL Business Ltd (GB) 2023-05-03 EP claimed
WO-2024197097-A2 COMPOSITIONS AND METHODS UTILIZING NOVEL MECHANISMS TARGETING CELL RESPONSES TO STRESS NEW YORK SOCIETY FOR THE RELIEF OF THE RUPTURED AND CRIPPLED, MAINTAINING THE HOSPITAL FOR SPECIAL SURGERY (US) 2024-09-26 WO disclosed
US-20230277538-A1 THERAPEUTICS FOR THE TREATMENT OF FSHD UCL BUSINESS LTD (GB) 2023-09-07 US disclosed